Last: 0.04
Change: 0.00
Vol: 0
European Funds
Republic of Poland
The National Centre of R&D
European Union

Medicinal Products for Targeted Cancer Treatments

WPD focuses on developing biological and chemical molecules involved in targeted therapy for brain glioma and other central nervous system cancers.

Last updated: 2022-06-28

About Us

WPD has 4 novel drug candidates with 1 that in in clinical development stage and 3 in pre-clinical development. These drug candidates were researched at institutions including the Mayo Clinic and Emory University. WPD currently has ongoing collaborations with Wake Forest University and leading hospitals and academic centers in Poland.

Subscribe to our Newsletter